ctrl K

Price Alert

Jade Biosciences Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD

7.33

0.56 (8.27%)

At close: Aug 15, 2025, 3:59 PM

7.30

-0.48%

After-hours: Aug 15, 2025, 07:20 PM EDT

Jade Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	69.39K	23.49M	22.4M	54.2M
Short-Term Investments	44.87M	98.95M	106.82M	113.18M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	-211.85K	2.28M	2.56M	302K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	250K	295K	240K
Total Current Assets	69.65K	124.23M	131.5M	174.33M
Property-Plant & Equipment	215K	902K	1.25M	728K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.15K	3.19M	3.8M	1.03M
Total Assets	72.8K	127.42M	135.3M	175.36M
Account Payables	1.29K	2.4M	2.58M	1.21M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	420K	385K	192K
Other Current Liabilities	1.08K	10.45M	3.13M	360K
Total Current Liabilities	12K	17.64M	7.78M	2.55M
Long-Term Debt	107.6K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	70K	71K	13K
Total Long-Term Liabilities	107.6K	325K	776K	395K
Total Liabilities	119.6K	17.96M	8.56M	2.94M
Total Debt	107.6K	675K	1.09M	574K
Common Stock	n/a	3K	2K	2K
Retained Earnings	-46.98K	-163.42M	-87.9M	-36.39M
Comprehensive Income	n/a	237K	-466K	-59K
Shareholders Equity	-46.8K	109.46M	126.74M	172.42M
Total Investments	44.87M	98.95M	106.82M	113.18M